John Zajicek is currently a Chair of Clinical Neuroscience with the Peninsula College of Medicine and Dentistry, and Honorary Consultant at Derriford Hospital in Plymouth. He has a background in cell biology and immunology while working in Cambridge, and then moved into more clinical surroundings when he joined the Plymouth team in 1995. Since then, he has been actively involved in developing neurology services (and coedited the Handbook of MS Care) and was Chief Investigator in the MRC funded Cannabinoids in MS (CAMS) trial. He is currently involved in a number of other clinical trials relating to MS, including the Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID), which is a 500 patient national trial, coordinated from Plymouth, investigating cannabinoids to slow progression in MS. He has also set up the South-West Impact of MS (SWIMS) project, which is following up 1300 people with MS in Devon and Cornwall, to provide new information about how MS changes over time, and to investigate new ways of conducting treatments trials. He is very optimistic that clinical research will produce new treatments for MS in the near future, not only for modifying the disease course in RRMS but also in slowing progression for people with progressive MS and improved treatment of symptoms.
Biography Updated on 15 November 2009